These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4218695)

  • 21. [Structure and function of clotting factor VIII: the results of fundamental research].
    Beck EA; Furlan M
    Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
    [No Abstract]   [Full Text] [Related]  

  • 22. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Factor VIII, haemophilia and von Willebrand's disease.
    S Afr Med J; 1974 Sep; 48(44):1853-4. PubMed ID: 4547189
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolism and distribution of fibrinogen. II. Fibrinogen turnover in polycythaemia, thrombocytosis, haemophilia A, congenital afibrinogenaemia and during streptokinase therapy.
    Tytgat GN; Collen D; Vermylen J
    Br J Haematol; 1972 Jun; 22(6):701-17. PubMed ID: 5037874
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
    Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
    Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilia part 1: an introduction.
    Khair K
    Br J Nurs; 2013 Jun 13-26; 22(11):620. PubMed ID: 23899729
    [No Abstract]   [Full Text] [Related]  

  • 27. [Occurrence of serum hepatitis following the administration of Cohn's fraction I or fibrinogen and antihemophilic globulin (AHG) respectively].
    Fábryová L; Hrubisko M
    Vnitr Lek; 1970 Feb; 16(2):123-6. PubMed ID: 5309309
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)].
    Fabris F; Betterle C; Casonato A; De Marco L; Girolami A
    Ric Clin Lab; 1979; 9(2 Suppl):51-63. PubMed ID: 395621
    [No Abstract]   [Full Text] [Related]  

  • 29. Von Willebrand disease, hemophilia A and B, and other factor deficiencies.
    Lee JW
    Int Anesthesiol Clin; 2004; 42(3):59-76. PubMed ID: 15205640
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C and pasteurised factor VIII and IX concentrates.
    Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
    Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
    Bennett B
    Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
    Fukui H
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oral administration of factor VIII or IX concentrate preparation].
    Sakuragawa N
    Rinsho Ketsueki; 1985 Jul; 26(7):1086-9. PubMed ID: 3932721
    [No Abstract]   [Full Text] [Related]  

  • 35. Cryoprecipitate therapy in haemophilia.
    Forbes CD; Hunter J; Barr RD; Davidson JF; Short DW; McDonald GA; McNicol GP; Wallace J; Douglas AS
    Scott Med J; 1969 Jan; 14(1):1-9. PubMed ID: 5304824
    [No Abstract]   [Full Text] [Related]  

  • 36. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
    West J Med; 1974 Mar; 120(3):226-32. PubMed ID: 4544608
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the liver condition in patients with congenital deficiency of plasma coagulation factors].
    Kowalewska B; Zalewska M
    Pol Arch Med Wewn; 1988 Jun; 79(6):296-306. PubMed ID: 3271306
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
    Ikeda Y; Handa M; Kawano K; Kamata T; Murata M; Araki Y; Anbo H; Kawai Y; Watanabe K; Itagaki I
    J Clin Invest; 1991 Apr; 87(4):1234-40. PubMed ID: 2010539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of von Willebrand's Disease.
    Mannucci PM
    N Engl J Med; 2004 Aug; 351(7):683-94. PubMed ID: 15306670
    [No Abstract]   [Full Text] [Related]  

  • 40. Independent stimulators regulating the production of coagulation factors VIII and IX in perfused spleens.
    Dodds WJ; Raymond SL; Moynihan AC; Fenton JW
    J Lab Clin Med; 1972 May; 79(5):770-7. PubMed ID: 4537012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.